Neurospine.  2019 Dec;16(4):728-738. 10.14245/ns.1836216.108.

Acidic Fibroblast Growth Factor in Spinal Cord Injury

Affiliations
  • 1Jhong Jheng Spine & Orthopedic Hospital, Kaohsiung, Taiwan.
  • 2Institute of Pharmacology, National Yang-Ming University, Taipei, Taiwan. chengch@gmail.com
  • 3School of Medicine, National Yang-Ming University, Taipei, Taiwan. wchuang518@gmail.com
  • 4Department of Neurosurgery, Neurological Institute, Taipei Veterans General Hospital, Taipei, Taiwan.
  • 5Taiwan International Graduate Program in Molecular Medicine, National Yang-Ming University and Academia Sinica, Taipei, Taiwan.

Abstract

Spinal cord injury (SCI), with an incidence rate of 246 per million person-years among adults in Taiwan, remains a devastating disease in the modern day. Elderly men with lower socioeconomic status have an even higher risk for SCI. Despite advances made in medicine and technology to date, there are few effective treatments for SCI due to limitations in the regenerative capacity of the adult central nervous system. Experiments and clinical trials have explored neuro-regeneration in human SCI, encompassing cell- and molecule-based therapies. Furthermore, strategies have aimed at restoring connections, including autologous peripheral nerve grafts and biomaterial scaffolds that theoretically promote axonal growth. Most molecule-based therapies target the modulation of inhibitory molecules to promote axonal growth, degrade glial scarring obstacles, and stimulate intrinsic regenerative capacity. Among them, acidic fibroblast growth factor (aFGF) has been investigated for nerve repair; it is mitogenic and pluripotent in nature and could enhance axonal growth and mitigate glial scarring. For more than 2 decades, the authors have conducted multiple trials, including human and animal experiments, using aFGF to repair nerve injuries, including central and peripheral nerves. In these trials, aFGF has shown promise for neural regeneration, and in the future, more trials and applications should investigate aFGF as a neurotrophic factor. Focusing on aFGF, the current review aimed to summarize the historical evolution of the utilization of aFGF in SCI and nerve injuries, to present applications and trials, to summarize briefly its possible mechanisms, and to provide future perspectives.

Keyword

Acidic fibroblast growth factor; Spinal cord injury; Regeneration

MeSH Terms

Adult
Aged
Animal Experimentation
Axons
Central Nervous System
Cicatrix
Fibroblast Growth Factor 1*
Humans
Incidence
Male
Peripheral Nerves
Regeneration
Social Class
Spinal Cord Injuries*
Spinal Cord*
Taiwan
Transplants
Fibroblast Growth Factor 1
Full Text Links
  • NS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr